Previous studies reported that patients with metabolic diseases such as those with T2DM or obesity display low-grade endotoxemia consequent to changes of proteins implicated in intestinal epithelial cell permeability, such as the tight junction (TJ) proteins ZO-1 or occludin [20]. This evidence concerns the gene OCLN and type 2 diabetes mellitus.